Nano, Encarnacion T.

HRN: 28-60-91  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/23/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/23/2026
03/02/2026
IV
2.25
Q8
Sepsis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines